Back
Open Access

Anti-fibrotic therapies.

Session: Lessons from recent and ongoing heart failure trials
Topic: Basic Science
Speaker: Professor T. Thum (Hannover, DE)
Event: Heart Failure 2020

Congress Presentation

About the speaker

Professor Thomas Thum

Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover (Germany)
27 presentations
2 followers

3 more presentations in this session

SGLT2-inhibitors for HFpEF?

Speaker: Doctor B. Westenbrink (Groningen, NL)

Access
Thumbnail

Neprilysin inhibition in HFpEF: is BNP involved?

Speaker: Professor A. Mebazaa (Paris, FR)

Access
Thumbnail

Interleukin -1 inhibitors.

Speaker: Doctor A. Abbate (Charlottesville, US)

Access
Thumbnail

Access the full session

Lessons from recent and ongoing heart failure trials

Speakers: Professor T. Thum, Doctor B. Westenbrink, Professor A. Mebazaa, Doctor A. Abbate
Access
Thumbnail

About the event

Image

Heart Failure 2020

23 May - 26 May 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb